Abon Pharmaceuticals LLC develops generic and proprietary drug products. Salah Ahmed founded the company in 2009 with attorney Bruce Downey and Sanford Bolton, a former pharmacy professor. Before founding Abon, Ahmed and Downey worked together at Barr Pharmaceuticals Inc., Downey as chairman and chief executive officer and Ahmed as chief scientific officer.
According to general counsel Heidi Kraus, the company is developing a variety of generic drugs, especially targeting areas with few competitors or where there are opportunities for new formulation, such as slow-release versions. Abon has yet to bring a drug to market. The Northvale, N.J., company is privately held and does not disclose its revenue. It has 42 employees and, Kraus said, the work force grew during the recession, although by less than 10 percent.
LEGAL TEAM AND OUTSIDE COUNSEL
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
